Victory Capital Management Inc Kaleido Biosciences, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$5.09 - $11.07 $382,131 - $831,080	-75,075 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$4.62 - $8.01 $231,512 - $401,389	-50,111 Reduced 40.03%	75,075 $558,000
Q1 2020 May 04, 2020	SELL	$3.62 - $9.49 $15,558 - $40,788	-4,298 Reduced 3.32%	125,186 $770,000
Q4 2019 Feb 06, 2020	SELL	$5.02 - $8.87 $90 - $159	-18 Reduced 0.01%	129,484 $650,000
Q4 2019 Feb 04, 2020	SELL	$5.02 - $8.87 $22,750 - $40,198	-4,532 Reduced 3.38%	129,502 $1.11 Million
Q3 2019 Nov 12, 2019	BUY	$6.74 - $11.3 $292,475 - $490,352	43,394 Added 47.88%	134,034 $1.01 Million
Q2 2019 Aug 15, 2019	SELL	$11.25 - $18.1 $58,500 - $94,120	-5,200 Reduced 5.43%	90,640 $1.05 Million
Q1 2019 May 03, 2019	BUY	$12.71 - $15.0 $1.22 Million - $1.44 Million	95,840 New	95,840 $1.39 Million

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.